DK0620727T3 - - Google Patents

Info

Publication number
DK0620727T3
DK0620727T3 DK93902033.5T DK93902033T DK0620727T3 DK 0620727 T3 DK0620727 T3 DK 0620727T3 DK 93902033 T DK93902033 T DK 93902033T DK 0620727 T3 DK0620727 T3 DK 0620727T3
Authority
DK
Denmark
Prior art keywords
plant
pellets
forming agent
gelatin
extracts
Prior art date
Application number
DK93902033.5T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Juergen Freidenreich
Juergen Werry
Ursula Schick
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4201179A external-priority patent/DE4201179A1/de
Priority claimed from DE4201172A external-priority patent/DE4201172C1/de
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Application granted granted Critical
Publication of DK0620727T3 publication Critical patent/DK0620727T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
DK93902033.5T 1992-01-17 1993-01-18 DK0620727T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4201179A DE4201179A1 (de) 1992-01-17 1992-01-17 Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE4201172A DE4201172C1 (en) 1992-01-17 1992-01-17 Pellets contg. Aloe vera extract - useful, e.g. as antiinflammatory of antibiotic agents, or for treating gastric ulcers
US07/876,876 US5387415A (en) 1992-01-17 1992-04-30 Aloe vera juice containing pellets process for production thereof and the use thereof as pharmaceutical, cosmetic and peroral agents
US07/876,866 US5401502A (en) 1992-01-17 1992-04-30 Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use

Publications (1)

Publication Number Publication Date
DK0620727T3 true DK0620727T3 (da) 1997-05-26

Family

ID=27435368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93902033.5T DK0620727T3 (da) 1992-01-17 1993-01-18

Country Status (10)

Country Link
EP (1) EP0620727B1 (da)
JP (1) JPH07502735A (da)
AT (1) ATE151631T1 (da)
AU (1) AU679905B2 (da)
CA (1) CA2128242C (da)
DE (1) DE59306197D1 (da)
DK (1) DK0620727T3 (da)
ES (1) ES2102637T3 (da)
GR (1) GR3024062T3 (da)
WO (1) WO1993013754A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128244C (en) 1992-01-17 1998-09-22 Jens-Christian Wunderlich Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
DE19603019C2 (de) * 1996-01-17 1998-10-15 Lancaster Group Gmbh Kosmetisches Hautreinigungsmittel auf Basis natürlicher Wirkstoffe
IL131317A (en) * 1999-08-09 2006-08-01 Cts Chemical Ind Ltd Binder for pharmaceutical compositions
JP2003160440A (ja) * 2001-11-26 2003-06-03 Mikimoto Pharmaceut Co Ltd 真珠層粉末
AU2003276011A1 (en) * 2002-10-16 2004-05-04 Dr. Suwelack Skin And Health Care Ag Use of molded bodies for external application
ES2549259T3 (es) 2003-04-11 2015-10-26 Cargill, Incorporated Sistemas granulares para preparar bebidas
JP5959852B2 (ja) * 2008-07-18 2016-08-02 カーギル・インコーポレイテッド 果汁を用いて製造した冷凍ペレット
EP4230187A1 (en) * 2022-02-21 2023-08-23 Biofactoria Naturae Et Salus Sa Single-dose cosmetic product and process of manufacturing thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE454386C (de) * 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form
GB242323A (en) * 1924-07-04 1925-11-04 Firm Knoll & Co Chem Fab An improved method of manufacturing medicinal jujubes
GB887901A (da) * 1960-04-13 1900-01-01
FR1397583A (fr) * 1964-05-04 1965-04-30 Hoffmann La Roche Procédé pour la préparation de compositions contenant des substances sensibles à l'oxydation
BE770604A (en) * 1971-07-28 1971-12-01 Hoffmann La Roche High potency vitamin e powders
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
ATE151631T1 (de) 1997-05-15
DE59306197D1 (de) 1997-05-22
WO1993013754A1 (de) 1993-07-22
JPH07502735A (ja) 1995-03-23
AU679905B2 (en) 1997-07-17
CA2128242A1 (en) 1993-07-22
EP0620727A1 (de) 1994-10-26
GR3024062T3 (en) 1997-10-31
EP0620727B1 (de) 1997-04-16
ES2102637T3 (es) 1997-08-01
CA2128242C (en) 1998-09-22
AU3343193A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
US5955438A (en) Collagen-based matrix
GR3027722T3 (en) Osteogenic devices
DK0506884T3 (da) Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
PL312387A1 (en) Proteinous microbeads of encapsulated non-dissolving gas and method of making them and their application as ultrasonic visualisation medium
NO174274C (no) Pigmenttilsetninger for dyreforblandinger, fremgangsmåte ved fremstilling og anvendelse derav
DK0620727T3 (da)
ES2039929T3 (es) Procedimiento para la preparacion de liposomas y/o celulas biologicas que contienen sustancias constitutivas, asi como su aplicacion.
EP0214879A3 (en) Process for sulfating glycosaminoglycanes, glycosaminoglycanes obtained and their biological applications
NO973848D0 (no) Fremgangsmåte til fremstilling av hemoglobinliknende protein
BR8801528A (pt) Processo de preparacao de particulas compactas compositas polimero/metal,particulas compositas calibradas polimero/metal,dispersoes aquosas de particulas compositas calibradas,processo de preparacao das particulas compositas calibradas e particulas compactas compositas polimero/metal
EP0824152A3 (en) Microbial production of vitamin B12 and production and use of compositions comprising high concentrations of vitamin B12 activity
DE59307073D1 (de) Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
Jeng et al. Purification and characterization of reversible sperm motility inhibitors from porcine seminal plasma
SI0672698T1 (en) Process for the preparation of optionally cellular polyurethanes and/or polyurethanecureas
YU49404B (sh) Nova smesa koja sadrži ciklosporin i poboljšani postupak za dobijanje mekih želatinskih kapsula koje sadrže ciklosporin
Andrews et al. Distribution and binding of glycosaminoglycan polysulfate to intervertebral disc, knee joint articular cartilage and meniscus
PT90298A (pt) Processo para a preparacao de derivados de pro-uroquinase de baixo peso molecular e de composicoes farmaceuticas que os contem
EA199800918A1 (ru) Происходящие от хозяина сигналы для индуцирования экспрессии гена изопреноида и их применение
Ruda et al. Colocalization of opioid peptide and fos protein in a rat model of peripheral inflammation and hyperalgesia
KR950018045A (ko) 신규 항생물질 하이판신 및 그의 제조방법
Nasledov The contractile properties of the frog muscle fiber in the intact and the skinned states
KR910700043A (ko) 타정시에 있어서 응력분산 방법
Favrot et al. Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988
PL292085A1 (en) Method of tanning proteinous substances, in particular those of plant origin such as proteins from iol plants and tanned proteinous substances obtained thereby